Диагностика старения
Список литературы

1. M. Law, N. Wald, J. Morris. (2003). Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health Technol. Assess. 7;
2. Prospective Studies Collaboration. (2002). Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet. 360, 1903–1913;
3. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green et. al. (2003). Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 42, 1206–1252;
4. Global Health Risks. Mortality and burden of disease attributable to selected major risks. (2009). WHO;
5. Krishnan Bhaskaran, Ian Douglas, Harriet Forbes, Isabel dos-Santos-Silva, David A. Leon, Liam Smeeth. (2014). Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. The Lancet. 384, 755–765;
6. Andrew Stokes, Samuel H. Preston. (2015). Smoking and reverse causation create an obesity paradox in cardiovascular disease. Obesity. 23, 2485–2490;
7. Gunilla Ringbäck Weitoft, Mats Eliasson, Måns Rosén. (2008). Underweight, overweight and obesity as risk factors for mortality and hospitalization. Scand. J. Public Health. 36, 169–176;
8. Prospective Studies Collaboration. (2009). Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. The Lancet. 373, 1083–1096;
9. Katherine M. Flegal. (2005). Excess Deaths Associated With Underweight, Overweight, and Obesity. JAMA. 293, 1861;
10. James R. Cerhan, Steven C. Moore, Eric J. Jacobs, Cari M. Kitahara, Philip S. Rosenberg et. al. (2014). A Pooled Analysis of Waist Circumference and Mortality in 650,000 Adults. Mayo Clinic Proceedings. 89, 335–345;
11. Bríain ó. Hartaigh, Heather G. Allore, Mark Trentalange, Gail McAvay, Stefan Pilz et. al. (2015). Elevations in time-varying resting heart rate predict subsequent all-cause mortality in older adults. Eur. J. Prev. Cardiolog. 22, 527–534;
12. James B. Carter, Eric W. Banister, Andrew P. Blaber. (2003). Effect of Endurance Exercise on Autonomic Control of Heart Rate. Sports Medicine. 33, 33–46;
13. Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S. Borer, Ian Ford et. al. (2010). Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. The Lancet. 376, 875–885;
14. Sarah E.R. Bailey, Obioha C. Ukoumunne, Elizabeth A. Shephard, Willie Hamilton. (2017). Clinical relevance of thrombocytosis in primary care: a prospective cohort study of cancer incidence using English electronic medical records and cancer registry data. Br. J. Gen. Pract. 67, e405–e413;
15. Paul B. Watkins, Neil Kaplowitz, John T. Slattery, Connie R. Colonese, Salvatore V. Colucci et. al. (2006). Aminotransferase Elevations in Healthy Adults Receiving 4 Grams of Acetaminophen Daily. JAMA. 296, 87;
16. D.G. Le Couteur, F.M. Blyth, H.M. Creasey, D.J. Handelsman, V. Naganathan et. al. (2010). The Association of Alanine Transaminase With Aging, Frailty, and Mortality. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 65A, 712–717;
17. Eran Elinav, Iddo Z. Ben-Dov, Elizabeth Ackerman, Alexander Kiderman, Frida Glikberg et. al. (2005). Correlation Between Serum Alanine Aminotransferase Activity and Age: An Inverted U Curve Pattern. Am. J. Gastroenterology. 100, 2201–2204;
18. Ian Ford, Simon P. Mooijaart, Suzanne Lloyd, Heather M. Murray, Rudi G.J. Westendorp et. al. (2011). The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. International Journal of Epidemiology. 40, 1530–1538;
19. E. Ramaty, E. Maor, N. Peltz-Sinvani, A. Brom, A. Grinfeld et. al. (2014). Low ALT blood levels predict long-term all-cause mortality among adults. A historical prospective cohort study. European Journal of Internal Medicine. 25, 919–921;
20. William Marshall. (2010). Albumin (serum, plasma). Association for Clinical Biochemistry UK;
21. Masaki T, Matsuura T, Ohkawa K, Miyamura T, Okazaki I, Watanabe T, Suzuki T. (2006). All-trans retinoic acid down-regulates human albumin gene expression through the induction of C/EBPbeta-LIP. Biochem J. 2006 Jul 15;397(2):345-53
22. H. Pasantes-Morales, C.E. Wright, G.E. Gaull. (1984). Protective Effect of Taurine, Zinc and Tocopherol on Retinol-Induced Damage in Human Lymphoblastoid Cells. The Journal of Nutrition. 114, 2256–2261;
23. Felipe Cabezas, Jonathan Lagos, Carlos Céspedes, Carlos P. Vio, Miguel Bronfman, María-Paz Marzolo. (2011). Megalin/LRP2 Expression Is Induced by Peroxisome Proliferator-Activated Receptor -Alpha and -Gamma: Implications for PPARs' Roles in Renal Function. PLoS ONE. 6, e16794;
24. Sander Kersten. (2008). Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism. PPAR Research. 2008, 1–11;
25. C. Janani, B.D. Ranjitha Kumari. (2015). PPAR gamma gene – A review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 9, 46–50;
26. Jin Lee, Eun Mi Hong, Dong Hee Koh, Min Ho Choi, Hyun Joo Jang et. al. (2010). HMG-CoA Reductase Inhibitors (Statins) Activate Expression of PPARα/PPARγ and ABCA1 in Cultured Gallbladder Epithelial Cells. Dig. Dis. Sci. 55, 292–299;
27. Jin Lee, Aimee Tauscher, Dong Wan Seo, John F. Oram, Rahul Kuver. (2003). Cultured gallbladder epithelial cells synthesize apolipoproteins A-I and E. American Journal of Physiology-Gastrointestinal and Liver Physiology. 285, G630–G641;
28. Peter Tontonoz, Bruce M. Spiegelman. (2008). Fat and Beyond: The Diverse Biology of PPARγ. Annu. Rev. Biochem. 77, 289–312;
29. Maria-Chiara Corti. (1994). Serum Albumin Level and Physical Disability as Predictors of Mortality in Older Persons. JAMA. 272, 1036;
30. Tomonori Okamura, Takehito Hayakawa, Atsushi Hozawa, Takashi Kadowaki, Yoshitaka Murakami et. al. (2008). Lower Levels of Serum Albumin and Total Cholesterol Associated with Decline in Activities of Daily Living and Excess Mortality in a 12–Year Cohort Study of Elderly Japanese. Journal of the American Geriatrics Society. 56, 529–535;
31. Marie A. Bernard, Paul A. Nakonezny, T. Michael Kashner. (1998). The Effect of Vitamin B12Deficiency on Older Veterans and Its Relationship to Health. Journal of the American Geriatrics Society. 46, 1199–1206;
32. Teodoro Bottiglieri. (2009). Folate, Vitamin B12, and Neuropsychiatric Disorders. Nutrition Reviews. 54, 382–390;
33. Robert Clarke. (2008). B-vitamins and prevention of dementia. Proc. Nutr. Soc. 67, 75–81;
34. C.C. Tangney, N.T. Aggarwal, H. Li, R.S. Wilson, C. DeCarli et. al. (2011). Vitamin B12, cognition, and brain MRI measures: A cross-sectional examination. Neurology. 77, 1276–1282;
35. H.-X. Wang, A. Wahlin, H. Basun, J. Fastbom, B. Winblad, L. Fratiglioni. (2001). Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology. 56, 1188–1194;
36. A. McCaddon, B. Regland, P. Hudson, G. Davies. (2002).
Functional vitamin B12 deficiency and Alzheimer disease. Neurology. 58, 1395–1399;
37. Vitamin B12. Fact Sheet for Health Professionals. (2016). National Institutes of Health (USA);
38. Oh R., Brown D.L. (2003). Vitamin B12 deficiency. Am. Fam. Physician. 67, 979–986;
39. N. Sethi, E. Robilotti, Y. Sadan. (2004). Neurological Manifestations Of Vitamin B-12 Deficiency. The Internet Journal of Nutrition and Wellness. 2(1);
40. Eussen S.J., de Groot L.C., Joosten L.W., Bloo R.J., Clarke R., Ueland P.M. et al. (2006). Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am. J. Clin. Nutr. 84, 361–370;
41. Anne-Mette Hvas, Svend Juul, Lise Lauritzen, Ebba Nexø, Jørgen Ellegaard. (2004). No effect of vitamin B-12 treatment on cognitive function and depression: a randomized placebo controlled study. Journal of Affective Disorders. 81, 269–273;
42. VITAL Trial Collaborative Group. (2003). Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J. Intern. Med. 254, 67–75;
43. J.H. Kang, N. Cook, J. Manson, J.E. Buring, C.M. Albert, F. Grodstein. (2008). A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. American Journal of Clinical Nutrition. 88, 1602–1610;
44. Paul S. Aisen. (2008). High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease. JAMA. 300, 1774;
45. Ethan M. Balk. (2007). Vitamin B6, B12, and Folic Acid Supplementation and Cognitive Function. Arch. Intern. Med. 167, 21;
46. M.J. Burton, C.J. Doree. (2003). Ear drops for the removal of ear wax;
47. Reem Malouf, John Grimley Evans. (2008). Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database of Systematic Reviews;
48. Yiting Zhang, Nathaniel W. Hodgson, Malav S. Trivedi, Hamid M. Abdolmaleky, Margot Fournier et. al. (2016). Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia. PLoS ONE. 11, e0146797;
48а. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease. Baker-Nigh A., Vahedi S., Goetz E. et al. // Brain, Vol. 138, Issue 6, 2015, Pages 1722–1737. https://doi.org/10.1093/brain/awv024 26 February 2015 https://academic.oup.com/brain/article/138/6/1722/2847057.
49. C.C. Tangney, Y. Tang, D.A. Evans, M.C. Morris. (2009). Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline. Neurology. 72, 361–367;
50. Dale E. Bredesen. (2014). Reversal of cognitive decline: A novel therapeutic program. Aging. 6, 707–717;
51. Johan Frederik Berg Arendt, Lars Pedersen, Ebba Nexo, Henrik Toft Sørensen. (2013). Elevated Plasma Vitamin B12 Levels as a Marker for Cancer: A Population-Based Cohort Study. JNCI: Journal of the National Cancer Institute. 105, 1799–1805;
52. Dilia Giuggioli, M. Colaci, G. Cassone, P. Fallahi, F. Lumetti et. al. (2017). Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature. Clin. Rheumatol. 36, 583–590;
53. R. Rizzoli, S. Boonen, M.-L. Brandi, O. Bruyère, C. Cooper et. al. (2013). Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Current Medical Research and Opinion. 29, 305–313;
54. Cedric F. Garland, June Jiwon Kim, Sharif Burgette Mohr, Edward Doerr Gorham, William B. Grant et. al. (2014). Meta-analysis of All-Cause Mortality According to Serum 25-Hydroxyvitamin D. Am. J. Public Health. 104, e43–e50;
55. Dimitrios T. Papadimitriou. (2017). The Big Vitamin D Mistake. J. Prev. Med. Public Health. 50, 278–281;
56. Cedric F. Garland, Edward D. Gorham, Sharif B. Mohr, Frank C. Garland. (2009). Vitamin D for Cancer Prevention: Global Perspective. Annals of Epidemiology. 19, 468–483;
57. Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., Heaney R.P. (2007). Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 85, 1586–1591;
58. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press, 2011;
59. Dimitrios T. Papadimitriou. (2017). The Big Vitamin D Mistake. J. Prev. Med. Public Health. 50, 278–281;
60. K.J. Ausk, E.J. Boyko, G.N. Ioannou. (2010). Insulin Resistance Predicts Mortality in Nondiabetic Individuals in the U.S. Diabetes Care. 33, 1179–1185;
61. Gianluca Perseghin, Giliola Calori, Guido Lattuada, Francesca Ragogna, Erika Dugnani et. al. (2012). Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up. Acta Diabetol. 49, 421–428;
62. Zhu T.H., Yin W., Gao S.W. (2004). The effect of Ca2+ channel blocker on insulin secretion in rat pancreatic islet cells. Zhonghua Nei Ke Za Zhi. 43, 29–32;
63. F. Baş, F. Darendeliler, D. Demirkol, R. Bundak, N. Saka, H. Günöz. (1999). Successful Therapy with Calcium Channel Blocker (Nifedipine) in Persistent Neonatal Hyperinsulinemic Hypoglycemia of Infancy. Journal of Pediatric Endocrinology and Metabolism. 12;
64. Claus Brandt, Bente K. Pedersen. (2010). The Role of Exercise-Induced Myokines in Muscle Homeostasis and the Defense against Chronic Diseases. Journal of Biomedicine and Biotechnology. 2010, 1–6;
65. Kaoru Tominaga. (2015). The emerging role of senescent cells in tissue homeostasis and pathophysiology. Pathobiology of Aging & Age-related Diseases. 5, 27743;
66. Yusuke Kanda, Mitsuhiko Osaki, Futoshi Okada. (2017). Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction. IJMS. 18, 867;
67. Che Dehai, Pan Bo, Tian Qiang, Shang Lihua, Liu Fang et. al. (2014). Enhanced invasion of lung adenocarcinoma cells after co-culture with THP-1–derived macrophages via the induction of EMT by IL-6. Immunology Letters. 160, 1–10;
68. Bàrbara Castellana, Trond Aasen, Gema Moreno-Bueno, Sandra E. Dunn, Santiago Ramón y Cajal. (2015). Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells. Oncotarget. 6;
69. Artemisia Kakourou, Charalampia Koutsioumpa, David S. Lopez, Judith Hoffman-Bolton, Gary Bradwin et. al. (2015). Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies. Cancer Causes Control. 26, 1449–1460;
70. Geng Tian, Jia Mi, Xiaodan Wei, Dongmei Zhao, Lingyan Qiao et. al. (2015). Circulating interleukin-6 and cancer: A meta-analysis using Mendelian randomization. Sci. Rep. 5;
71. Yusuke Kanda, Mitsuhiko Osaki, Futoshi Okada. (2017). Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction. IJMS. 18, 867;
72. Qu Chen, Bin Xu, Lei Lan, Da Yang, Min Yang et. al. (2017). High mRNA expression level of IL-6R was associated with better prognosis for patients with ovarian cancer: a pooled meta-analysis. Sci. Rep. 7;
73. Martin Whitham, Mark A. Febbraio. (2016). The ever-expanding myokinome: discovery challenges and therapeutic implications. Nat. Rev. Drug Discov. 15, 719–729;
74. Kristian Karstoft, Bente K. Pedersen. (2016). Skeletal muscle as a gene regulatory endocrine organ. Current Opinion in Clinical Nutrition and Metabolic Care. 19, 270–275;
75. Neha Mathur, Bente Klarlund Pedersen. (2008). Exercise as a Mean to Control Low-Grade Systemic Inflammation. Mediators of Inflammation. 2008, 1–6;
76. Eileen McNeill, Keith M. Channon, David R. Greaves. (2010). Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications. Clin. Sci. 118, 641–655;
77. David A. Raichlen, Gene E. Alexander. (2014). Exercise, APOE genotype, and the evolution of the human lifespan. Trends in Neurosciences. 37, 247–255;
78. Ayman A. Hussein, John S. Gottdiener, Traci M. Bartz, Nona Sotoodehnia, Christopher DeFilippi et. al. (2013). Inflammation and sudden cardiac death in a community-based population of older adults: The Cardiovascular Health Study. Heart Rhythm. 10, 1425–1432;
79. J.M. Luna, Y.P. Moon, K.M. Liu, S. Spitalnik, M.C. Paik et. al. (2014). High-Sensitivity C-Reactive Protein and Interleukin-6–Dominant Inflammation and Ischemic Stroke Risk: The Northern Manhattan Study. Stroke. 45, 979–987;
80. Monika Puzianowska-Kuźnicka, Magdalena Owczarz, Katarzyna Wieczorowska-Tobis, Pawel Nadrowski, Jerzy Chudek et. al. (2016). Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study. Immun. Ageing. 13;
81. Wan-Ying Li, Fei-Mi Li, Yu-Fu Zhou, Zhong-Min Wen, Juan Ma et. al. (2016). Aspirin down Regulates Hepcidin by Inhibiting NF-κB and IL6/JAK2/STAT3 Pathways in BV-2 Microglial Cells Treated with Lipopolysaccharide. IJMS. 17, 1921;
82. Elisa Brighenti, Ferdinando Antonino Giannone, Francesca Fornari, Carmine Onofrillo, Marzia Govoni et. al. (2016). Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate. Oncotarget. 7;
83. Chul Kim, Xuehong Zhang, Andrew T. Chan, Howard D. Sesso, Nader Rifai et. al. (2016). Inflammatory biomarkers, aspirin, and risk of colorectal cancer: Findings from the physicians' health study. Cancer Epidemiology. 44, 65–70;
84. Ming-Min Chung, Christopher J. Nicol, Yi-Chuan Cheng, Kuan-Hung Lin, Yen-Lin Chen et. al. (2017). Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs. Experimental Cell Research. 352, 75–83;
85. Wei Chen, Xiaojie Liu, Shandong Ye. (2016). Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes. J. Inflamm. 13;
86. Hana Malínská, Olena Oliyarnyk, Vojtěch Škop, Jan Šilhavý, Vladimír Landa et. al. (2016). Effects of Metformin on Tissue Oxidative and Dicarbonyl Stress in Transgenic Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein. PLoS ONE. 11, e0150924;
87. Xiaoyun Tang, Xianyan Wang, Yuan Y. Zhao, Jonathan M. Curtis, David N. Brindley. (2017). Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation. Mol. Cancer. 16;
88. Ming Li, Wenping Yao, Shenqiang Li, Juan Xi. (2015). Norepinephrine induces the expression of interleukin-6 via β-adrenoreceptor-NAD(P)H oxidase system -NF-κB dependent signal pathway in U937 macrophages. Biochemical and Biophysical Research Communications. 460, 1029–1034;
89. E.R. Hahm, S.V. Singh. (2010). Sulforaphane Inhibits Constitutive and Interleukin-6–Induced Activation of Signal Transducer and Activator of Transcription 3 in Prostate Cancer Cells. Cancer Prevention Research. 3, 484–494;
90. Min Wei, Sebastian Brandhorst, Mahshid Shelehchi, HaMed. Mirzaei, Chia Wei Cheng et. al. (2017). Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci. Transl. Med. 9, eaai8700;
91. Manuel Heras, María José Fernández-Reyes. (2017). Concentraciones séricas de potasio: importancia de la normopotasemia. Medicina Clínica. 148, 562–565;
92. Sehoon Park, Seon Ha Baek, Sung Woo Lee, Anna Lee, Ho Jun Chin et. al. (2017). Elevated baseline potassium level within reference range is associated with worse clinical outcomes in hospitalised patients. Sci. Rep. 7;
93. Taehee Kim, Connie M. Rhee, Elani Streja, Melissa Soohoo, Yoshitsugu Obi et. al. (2017). Racial and Ethnic Differences in Mortality Associated with Serum Potassium in a Large Hemodialysis Cohort. Am. J. Nephrol. 45, 509–521;
94. Zhaoran Chen, Bi Huang, Haisong Lu, Zhenhua Zhao, Rutai Hui et. al. (2017). The effect of admission serum potassium levels on in-hospital and long-term mortality in type A acute aortic dissection. Clinical Biochemistry. 50, 843–850;
95. Chiara Donfrancesco, Simonetta Palleschi, Luigi Palmieri, Barbara Rossi, Cinzia Lo Noce et. al. (2013). Estimated Glomerular Filtration Rate, All-Cause Mortality and Cardiovascular Diseases Incidence in a Low Risk Population: The MATISS Study. PLoS ONE. 8, e78475;
96. Sabina Zambon, Stefania Maggi, Silvia Zanoni, Giovanna Romanato, Marianna Noale et. al. (2012). Association of single measurement of estimated glomerular filtration rate and non-quantitative dipstick proteinuria with all-cause and cardiovascular mortality in the elderly. Results from the Progetto Veneto Anziani (Pro.V.A.) Study. Atherosclerosis. 220, 201–207;
97. S.W. Oh, S.H. Baek, Y.C. Kim, H.S. Goo, N.J. Heo et. al. (2012). Mild decrease in estimated glomerular filtration rate and proteinuria are associated with all-cause and cardiovascular mortality in the general population. Nephrology Dialysis Transplantation. 27, 2284–2290;
98. P. Muntner, C.B. Bowling, L. Gao, D. Rizk, S. Judd et. al. (2011). Age-Specific Association of Reduced Estimated Glomerular Filtration Rate and Albuminuria with All-Cause Mortality. Clinical Journal of the American Society of Nephrology. 6, 2200–2207;
99. Muntner P., He J., Hamm L., Loria C., Whelton P.K. (2002). Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J. Am. Soc. Nephrol. 13, 745–53;
100. Amanda J. Cox, Fang-Chi Hsu, J. Carr, Barry I. Freedman, Donald W. Bowden. (2013). Glomerular filtration rate and albuminuria predict mortality independently from coronary artery calcified plaque in the Diabetes Heart Study. Cardiovasc Diabetol. 12, 68;

201. G. Dickstein, C. Shechner, F. Adawi, J. Kaplan, E. Baron, S. Ish-Shalom. (1997). Lithium treatment in amiodarone-induced thyrotoxicosis. The American Journal of Medicine. 102, 454–458;
202. Alessandro Prete, Rosa Maria Paragliola, Salvatore Maria Corsello. (2015). Iodine Supplementation: Usage "with a Grain of Salt". International Journal of Endocrinology. 2015, 1–8;
203. Xin Sun, Zhongyan Shan, Weiping Teng. (2014). Effects of Increased Iodine Intake on Thyroid Disorders. Endocrinol Metab. 29, 240;
204. W Reinhardt, M Luster, K. Rudorff, C Heckmann, S Petrasch et. al. (1998). Effect of small doses of iodine on thyroid function in patients with Hashimoto's thyroiditis residing in an area of mild iodine deficiency. European Journal of Endocrinology. 139, 23–28;
205. Lyn Patrick. (2008). Iodine: Deficiencyand Therapeutic Considerations. Alternative Medicine Review. 2, 116–127;
206. Aleksandra Pyzik, Ewelina Grywalska, Beata Matyjaszek-Matuszek, Jacek Roliński. (2015). Immune Disorders in Hashimoto's Thyroiditis: What Do We Know So Far?. Journal of Immunology Research. 2015, 1–8;
207. Overview of Dietary Reference Intakes for Japanese. (2015). Ministry of Health, Labour and Welfare;
208. Bjørn O. Åsvold, Trine Bjøro, Tom Ivar L. Nilsen, David Gunnell, Lars J. Vatten. (2008). Thyrotropin Levels and Risk of Fatal Coronary Heart Disease. Arch. Intern. Med. 168, 855;
209. Kosuke Inoue, Tetsuro Tsujimoto, Jun Saito, Takehiro Sugiyama. (2016). Association Between Serum Thyrotropin Levels and Mortality Among Euthyroid Adults in the United States. Thyroid. 26, 1457–1465;
210. Jennifer S. Mammen, John McGready, Paul W. Ladenson, Eleanor M. Simonsick. (2017). Unstable Thyroid Function in Older Adults Is Caused by Alterations in Both Thyroid and Pituitary Physiology and Is Associated with Increased Mortality. Thyroid. 27, 1370–1377;
211. Priyathama Vellanki. (2014). How Doctors Diagnose Hypothyroidism. Vertical Health;
212. Jeffrey Garber, Rhoda Cobin, Hossein Gharib, James Hennessey, Irwin Klein et. al. (2012). Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocrine Practice. 18, 988–1028;
213. Hypothyroidism. (2015). British Thyroid Foundation;
214. J. Parle, L. Roberts, S. Wilson, H. Pattison, A. Roalfe et. al. (2010). A Randomized Controlled Trial of the Effect of Thyroxine Replacement on Cognitive Function in Community-Living Elderly Subjects with Subclinical Hypothyroidism: The Birmingham Elderly Thyroid Study. The Journal of Clinical Endocrinology & Metabolism. 95, 3623–3632;
215. Isabela Bensenor, Paulo Lotufo, Diaz-Olmos. (2012). Hypothyroidism in the elderly: diagnosis and management. CIA. 97;
216. Robin P. Peeters. (2009). Thyroid Function and Longevity: New Insights into an Old Dilemma. The Journal of Clinical Endocrinology & Metabolism. 94, 4658–4660;
217. A. Iqbal, R. Jorde, Y. Figenschau. (2006). Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromso Study. J. Intern. Med. 260, 53–61;
218. Nadia Caraccio, Ele Ferrannini, Fabio Monzani. (2002). Lipoprotein Profile in Subclinical Hypothyroidism: Response to Levothyroxine Replacement, a Randomized Placebo-Controlled Study. The Journal of Clinical Endocrinology & Metabolism. 87, 1533–1538;
219. Nicolas Rodondi, Douglas C. Bauer, Anne R. Cappola, Jacques Cornuz, John Robbins et. al. (2008). Subclinical Thyroid Dysfunction, Cardiac Function, and the Risk of Heart Failure. Journal of the American College of Cardiology. 52, 1152–1159;
220. Nicolas Rodondi, Wendy P.J. den Elzen, Douglas C. Bauer, Anne R. Cappola, Salman Razvi et. al. (2010). Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality. JAMA. 304, 1365;
221. Salman Razvi, Abdul Shakoor, Mark Vanderpump, Jolanta U. Weaver, Simon H.S. Pearce. (2008). The Influence of Age on the Relationship between Subclinical Hypothyroidism and Ischemic Heart Disease: A Metaanalysis. The Journal of Clinical Endocrinology & Metabolism. 93, 2998–3007;
222. Christine McQuade, Mario Skugor, Danielle M. Brennan, Brian Hoar, Cindy Stevenson, Byron J. Hoogwerf. (2011). Hypothyroidism and Moderate Subclinical Hypothyroidism Are Associated with Increased All-Cause Mortality Independent of Coronary Heart Disease Risk Factors: A PreCIS Database Study. Thyroid. 21, 837–843;
223. H. Brownborg. (2007). Hormonal regulation of longevity in mammals. Ageing Research Reviews. 6, 28–45;
224. Adam Gesing. (2015). The thyroid gland and the process of aging. Thyroid Research. 8, A8;
225. Hiroshi Ooka, Saori Fujita, Emiko Yoshimoto. (1983). Pituitary-thyroid activity and longevity in neonatally thyroxine-treated rats. Mechanisms of Ageing and Development. 22, 113–120;
226. Hiroshi Ooka, Tadashi Shinkai. (1986). Effects of chronic hyperthyroidism on the lifespan of the rat. Mechanisms of Ageing and Development. 33, 275–282;
227. H. Brownborg. (2007). Hormonal regulation of longevity in mammals. Ageing Research Reviews. 6, 28–45;
228. Vergara M., Smith-Wheelock M., Harper J.M., Sigler R., Miller R.A. (2004). Hormone-treated snell dwarf mice regain fertility but remain long lived and disease resistant. J. Gerontol. A Biol. Sci. Med. Sci. 59, 1244–1250;
229. Yael H. Edrey, Thomas J. Park, Hyesin Kang, Adriana Biney, Rochelle Buffenstein. (2011). Endocrine function and neurobiology of the longest-living rodent, the naked mole-rat. Experimental Gerontology. 46, 116–123;
230. Rochelle Buffenstein, Mario Pinto. (2009). Endocrine function in naturally long-living small mammals. Molecular and Cellular Endocrinology. 299, 101–111;
231. J. Bowers, J. Terrien, M.S. Clerget-Froidevaux, J.D. Gothié, M.P. Rozing et. al. (2013). Thyroid Hormone Signaling and Homeostasis During Aging. Endocrine Reviews. 34, 556–589;
232. Jacobijn Gussekloo. (2004). Thyroid Status, Disability and Cognitive Function, and Survival in Old Age. JAMA. 292, 2591;
233. Björn Schumacher, George A. Garinis, Jan H.J. Hoeijmakers. (2008). Age to survive: DNA damage and aging. Trends in Genetics. 24, 77–85;
234. Gil Atzmon, Nir Barzilai, Joseph G. Hollowell, Martin I. Surks, Ilan Gabriely. (2009). Extreme Longevity Is Associated with Increased Serum Thyrotropin. The Journal of Clinical Endocrinology & Metabolism. 94, 1251–1254;
235. M.P. Rozing, J.J. Houwing-Duistermaat, P.E. Slagboom, M. Beekman, M. Frölich et. al. (2010). Familial Longevity Is Associated with Decreased Thyroid Function. The Journal of Clinical Endocrinology & Metabolism. 95, 4979–4984;
236. Gil Atzmon, Nir Barzilai, Martin I. Surks, Ilan Gabriely. (2009). Genetic Predisposition to Elevated Serum Thyrotropin Is Associated with Exceptional Longevity. The Journal of Clinical Endocrinology & Metabolism. 94, 4768–4775;
237. Lisette Arnaud-Lopez, Gianluca Usala, Graziano Ceresini, Braxton D. Mitchell, Maria Grazia Pilia et. al. (2008). Phosphodiesterase 8B Gene Variants Are Associated with Serum TSH Levels and Thyroid Function. The American Journal of Human Genetics. 82, 1270–1280;
238. Elizabeth Carpio-Rivera, José Moncada-Jiménez, Walter Salazar-Rojas, Andrea Solera-Herrera. (2016). Acute Effects of Exercise on Blood Pressure: A Meta-Analytic Investigation. Arquivos Brasileiros de Cardiologia;
239. Gianluca Rospo, Viola Valsecchi, Alberto G Bonomi, Inge W.J. Thomassen, Saskia van Dantzig et. al. (2016). Cardiorespiratory Improvements Achieved by American College of Sports Medicine's Exercise Prescription Implemented on a Mobile App. JMIR Mhealth Uhealth. 4, e77;
240. Masataka Iwane, Mikio Arita, Shigehiro Tomimoto, Osamu Satani, Masanobu Matsumoto et. al. (2000). Walking 10,000 Steps/Day or More Reduces Blood Pressure and Sympathetic Nerve Activity in Mild Essential Hypertension.. Hypertens Res. 23, 573–580;
241. Catrine Tudor-Locke, Damon L. Swift, John M. Schuna, Amber T. Dragg, Allison B. Davis et. al. (2014). WalkMore: a randomized controlled trial of pedometer-based interventions differing on intensity messages. BMC Public Health. 14;
242. Leryn J. Boyle, Daniel P. Credeur, Nathan T. Jenkins, Jaume Padilla, Heather J. Leidy et. al. (2013). Impact of reduced daily physical activity on conduit artery flow-mediated dilation and circulating endothelial microparticles. Journal of Applied Physiology. 115, 1519–1525;
243. V.A. Cornelissen, N.A. Smart. (2013). Exercise Training for Blood Pressure: A Systematic Review and Meta-analysis. Journal of the American Heart Association. 2, e004473–e004473;
244. L. Mosca, E.J. Benjamin, K. Berra, J.L. Bezanson, R.J. Dolor et. al. (2011). Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women--2011 Update: A Guideline From the American Heart Association. Circulation. 123, 1243–1262;
245. Stephen B. Manuck, Jay R. Kaplan, Michael R. Adams, Thomas B. Clarkson. (1988). Effects of stress and the sympathetic nervous system on coronary artery atherosclerosis in the cynomolgus macaque. American Heart Journal. 116, 328–333;
246. Laura Blue. (2012). Strongest Study Yet Shows Meditation Can Lower Risk of Heart Attack and Stroke. Time;
247. J.E. Gangwisch, S.B. Heymsfield, B. Boden-Albala, R.M. Buijs, F. Kreier et. al. (2006). Short Sleep Duration as a Risk Factor for Hypertension: Analyses of the First National Health and Nutrition Examination Survey. Hypertension. 47, 833–839;
248. F.P. Cappuccio, S. Stranges, N.-B. Kandala, M.A. Miller, F.M. Taggart et. al. (2007). Gender-Specific Associations of Short Sleep Duration With Prevalent and Incident Hypertension: The Whitehall II Study. Hypertension. 50, 693–700;
249. Velthuis-te Wierik E.J., van den Berg H., Schaafsma G., Hendriks H.F., Brouwer A. (1994). Energy restriction, a useful intervention to retard human ageing? Results of a feasibility study. Eur. J. Clin. Nutr. 48, 138–148;
250. Simon L. Bacon, Andrew Sherwood, Alan Hinderliter, James A. Blumenthal. (2004). Effects of Exercise, Diet and Weight Loss on High Blood Pressure. Sports Medicine. 34, 307–316;
251. Rachel K. Johnson, Bethany A. Yon. (2010). Weighing in on Added Sugars and Health. Journal of the American Dietetic Association. 110, 1296–1299;
252. I.J. Brown, J. Stamler, L. Van Horn, C.E. Robertson, Q. Chan et. al. (2011). Sugar-Sweetened Beverage, Sugar Intake of Individuals, and Their Blood Pressure: International Study of Macro/Micronutrients and Blood Pressure. Hypertension. 57, 695–701;
253. James J. DiNicolantonio, Sean C. Lucan. (2014). The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease. Open Heart. 1, e000167;
254. R. Dhingra, L. Sullivan, P.F. Jacques, T.J. Wang, C.S. Fox et. al. (2007). Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults in the Community. Circulation. 116, 480–488;
255. L. Chen, B. Caballero, D.C. Mitchell, C. Loria, P.-H. Lin et. al. (2010). Reducing Consumption of Sugar-Sweetened Beverages Is Associated With Reduced Blood Pressure: A Prospective Study Among United States Adults. Circulation. 121, 2398–2406;
256. Sailesh Mohan, Norm R.C. Campbell. (2009). Salt and high blood pressure. Clin. Sci. 117, 1–11;
257. Ute Hettinger, Martina Lukasova, Sabina Lewicka, Ulrich Hilgenfeldt. (2002). Regulatory effects of salt diet on renal renin–angiotensin–aldosterone, and kallikrein–kinin systems. International Immunopharmacology. 2, 1975–1980;
258. Chris Tikellis, Raelene J. Pickering, Despina Tsorotes, Valma Harjutsalo, Lena Thorn et. al. (2013). Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetes. Clin. Sci. 124, 617–626;
259. C. Tikellis, R.J. Pickering, D. Tsorotes, O. Huet, J. Chin-Dusting et. al. (2012). Activation of the Renin-Angiotensin System Mediates the Effects of Dietary Salt Intake on Atherogenesis in the Apolipoprotein E Knockout Mouse. Hypertension. 60, 98–105;
260. Ian B. Puddey, Lawrence J. Beilin. (2006). ALCOHOL IS BAD FOR BLOOD PRESSURE. Clin. Exp. Pharmacol. Physiol. 33, 847–852;
261. Ho Ming Cheng, Georgios Koutsidis, John K. Lodge, Ammar Ashor, Mario Siervo, José Lara. (2017). Tomato and lycopene supplementation and cardiovascular risk factors: A systematic review and meta-analysis. Atherosclerosis. 257, 100–108;
262. Ho M. Cheng, Georgios Koutsidis, John K. Lodge, Ammar W. Ashor, Mario Siervo, Jose Lara. (2017). Lycopene and tomato and risk of cardiovascular diseases: A systematic review and meta-analysis of epidemiological evidence. Critical Reviews in Food Science and Nutrition. 1–18;
263. Alan Goldhamer, Douglas Lisle, Banoo Parpia, Scott V. Anderson, T.Colin Campbell. (2001). Medically supervised water-only fasting in the treatment of hypertension. Journal of Manipulative and Physiological Therapeutics. 24, 335–339;
264. Dehghan P., Pourghassem Gargari B., Asgharijafarabadi M. (2013). Effects of high performance inulin supplementation on glycemic status and lipid profile in women with type 2 diabetes: a randomized, placebo-controlled clinical trial. Health Promot. Perspect. 3, 55–63;
265. Mahdieh Abbasalizad Farhangi, Ahmad Zare Javid, Parvin Dehghan. (2016). The effect of enriched chicory inulin on liver enzymes, calcium homeostasis and hematological parameters in patients with type 2 diabetes mellitus: A randomized placebo-controlled trial. Primary Care Diabetes. 10, 265–271;
266. Reis S.A., Conceição L.L., Rosa D.D., Dias M.M., Peluzio Mdo C. (2014). Mechanisms used by inulin-type fructans to improve the lipid profile. Nutr. Hosp. 31, 528–534;
267. Shyamala Dakshinamurti, Krishnamurti Dakshinamurti. (2015). Antihypertensive and neuroprotective actions of pyridoxine and its derivatives. Can. J. Physiol. Pharmacol. 93, 1083–1090;
268. Pak C.Y. (2000). Correction of thiazide-induced hypomagnesemia by potassium-magnesium citrate from review of prior trials. Clin. Nephrol. 54, 271–275;
269. Uwe Gröber, Joachim Schmidt, Klaus Kisters. (2015). Magnesium in Prevention and Therapy. Nutrients. 7, 8199–8226;
270. William S. Yancy, Maren K. Olsen, John R. Guyton, Ronna P. Bakst, Eric C. Westman. (2004). A Low-Carbohydrate, Ketogenic Diet versus a Low-Fat Diet To Treat Obesity and Hyperlipidemia. Ann. Intern. Med. 140, 769;
271. George A. Bray, Frank L. Greenway. (1999). Current and Potential Drugs for Treatment of Obesity. Endocrine Reviews. 20, 805–875;
272. Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S. Borer, Ian Ford et. al. (2010). Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. The Lancet. 376, 875–885;
273. Kubilay Cinar, Sahin Coban, Ramazan Idilman, Ali Tuzun, Mustafa Sarioglu et. al. (2006). Long-term prognosis of nonalcoholic fatty liver disease: Is pharmacological therapy actually necessary?. Journal of Gastroenterology and Hepatology. 21, 169–173;
274. Masahiro Kikuchi. (2015). Sulforaphane-rich broccoli sprout extract improves hepatic abnormalities in male subjects. WJG. 21, 12457;
275. Rabab H. Sayed, Wagdy K.B. Khalil, Hesham A. Salem, Sanaa A. kenawy, Bahia M. El-Sayeh. (2014). Sulforaphane increases the survival rate in rats with fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide. Nutrition Research. 34, 982–989;
276. Панькив В.И. (2013). Сахарный диабет 2-го типа и неалкогольная жировая болезнь печени. Эффекты метморфина. Международный эндокринологический журнал. 5;
277. R. Loomba, G. Lutchman, D.E. Kleiner, M. Ricks, J.J. Feld et. al. (2009). Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics. 29, 172–182;
278. Madrigal-Perez V.M., García-Rivera A., Rodriguez-Hernandez A., Ceja-Espiritu G., Briseño-Gomez X.G., Galvan-Salazar H.R. et al. (2015). Preclinical analysis of nonsteroidal anti-inflammatory drug usefulness for the simultaneous prevention of steatohepatitis, atherosclerosis and hyperlipidemia. Int. J. Clin. Exp. Med. 8, 22477–22483;
279. Teruo Miyazaki, Yasushi Matsuzaki. (2014). Taurine and liver diseases: a focus on the heterogeneous protective properties of taurine. Amino Acids. 46, 101–110;
280. Tom R. Thomas, Shana O. Warner, Kevin C. Dellsperger, Pamela S. Hinton, Adam T. Whaley-Connell et. al. (2010). Exercise and the metabolic syndrome with weight regain. Journal of Applied Physiology. 109, 3–10;
281. Zhu T.H., Yin W., Gao S.W. (2004). The effect of Ca2+ channel blocker on insulin secretion in rat pancreatic islet cells. Zhonghua Nei Ke Za Zhi. 43, 29–32;
282. Bakhtyar Tartibian, Behzad Hajizadeh Maleki, Jill Kanaley, Karim Sadeghi. (2011). Long-term aerobic exercise and omega-3 supplementation modulate osteoporosis through inflammatory mechanisms in post-menopausal women: a randomized, repeated measures study. Nutrition & Metabolism. 8, 71;
283. Ho Ming Cheng, Georgios Koutsidis, John K. Lodge, Ammar Ashor, Mario Siervo, José Lara. (2017). Tomato and lycopene supplementation and cardiovascular risk factors: A systematic review and meta-analysis. Atherosclerosis. 257, 100–108;
284. T. Krakauer, M. Buckley. (2003). Doxycycline Is Anti-Inflammatory and Inhibits Staphylococcal Exotoxin-Induced Cytokines and Chemokines. Antimicrobial Agents and Chemotherapy. 47, 3630–3633;
285. Bo-hyun Choi, Kyung-Shin Kang, Mi-Kyoung Kwak. (2014). Effect of Redox Modulating NRF2 Activators on Chronic Kidney Disease. Molecules. 19, 12727–12759;
286. T. Matsui, S. Yamagishi, S. Ueda, K. Nakamura, T. Imaizumi et. al. (2007). Telmisartan, an Angiotensin II Type 1 Receptor Blocker, Inhibits Advanced Glycation End-product (AGE)-induced Monocyte Chemoattractant Protein-1 Expression in Mesangial Cells through Downregulation of Receptor for AGEs via Peroxisome Proliferator-activated Receptor-γ Activation. J. Int. Med. Res. 35, 482–489;
287. Daisuke Mikami, Hideki Kimura, Kazuko Kamiyama, Kunio Torii, Kenji Kasuno et. al. (2014). Telmisartan activates endogenous peroxisome proliferator-activated receptor-δ and may have anti-fibrotic effects in human mesangial cells. Hypertens. Res. 37, 422–431;
288. Давыдова И.В. (2014). Сартаны при артериальной гипертензии: одним препаратом поражаем две мишени. Артериальная гипертензия. 3;
289. Carlos Alexandre Fett, Waléria Christiane Rezende Fett, Julio Sérgio Marchini. (2009). Exercício resistido vs jogging em fatores de risco metabólicos de mulheres com sobrepeso/obesas. Arq. Bras. Cardiol. 93, 519–525;
290. Kimura N., Ito T. (2004). Effect of optimum jogging in a hot environment on uric acid metabolism. Nihon Eiseigaku Zasshi. 59, 38–44;
291. Bernhard F. Gibbs, Isabel Gonçalves Silva, Alexandr Prokhorov, Maryam Abooali, Inna Yasinska et. al. (2015). Caffeine affects the biological responses of human hematopoietic cells of myeloid lineage via downregulation of the mTOR pathway and xanthine oxidase activity. Oncotarget. 6;
292. Charles Y.C. Pak. (2008). Medical Stone Management: 35 Years of Advances. The Journal of Urology. 180, 813–819;
293. P.O. Schwille, A. Schmiedl, R. Schwille, P. Brunner, H. Kissler et. al. (2003). Media calcification, low erythrocyte magnesium, altered plasma magnesium, and calcium homeostasis following grafting of the thoracic aorta to the infrarenal aorta in the rat—differential preventive effects of long-term oral magnesium supplementation alone and in combination with alkali. Biomedicine & Pharmacotherapy. 57, 88–97;
294. Morgan E. Levine, Jorge A. Suarez, Sebastian Brandhorst, Priya Balasubramanian, Chia-Wei Cheng et. al. (2014). Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population. Cell Metabolism. 19, 407–417;
295. Dongge Cai, Hongli Sun, Yanhua Qi, Xiaogui Zhao, Minjuan Feng, Xiaoling Wu. (2016). Insulin-Like Growth Factor 1/Mammalian Target of Rapamycin and AMP-Activated Protein Kinase Signaling Involved in the Effects of Metformin in the Human Endometrial Cancer. International Journal of Gynecological Cancer. 26, 1667–1672;
296. Vladimir N. Anisimov. (2010). Metformin for aging and cancer prevention. Aging. 2, 760–774;
297. Ki-Hoon Song, Ju-Hee Kang, Jong-Kyu Woo, Jeong-Seok Nam, Hye-Young Min et. al. (2014). The novel IGF-IR/Akt–dependent anticancer activities of glucosamine. BMC Cancer. 14;
298. Strobel G.A., Hess W.M. (1974). Evidence for the presence of the toxin-binding protein on the plasma membrane of sugarcane cells. Proc. Natl. Acad. Sci. USA. 71, 1413–1417;
299. Kinnucan J.A., Rubin D.T., Ali T. (2013). Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation. Gastroenterol. Hepatol. (NY). 9, 718–727;
300. Brinch L., Tjønnfjord G., Ly B. (1990). Folic acid deficiency can cause severe anemia and pancytopenia. Tidsskr Nor. Laegeforen. 110, 1830–1831;

301. Auders A.G., Aksik I.A., Kikut R.P., Irbe D.L. (1990). Diagnosis of vascular compression of the trigeminal and glossopharyngeal nerve roots. Zh. Nevropatol. Psikhiatr. Im. S.S. Korsakova. 90, 8–11;
302. Takako Maki, Ngoc Minh Pham, Daigo Yoshida, Guang Yin, Keizo Ohnaka et. al. (2010). The relationship of coffee and green tea consumption with high-sensitivity C-reactive protein in Japanese men and women. Clinical Chemistry and Laboratory Medicine. 48;
303. Jacob Selhub, Alexander Byun, Zhenhua Liu, Joel B. Mason, Roderick T. Bronson, Jimmy W. Crott. (2013). Dietary vitamin B6 intake modulates colonic inflammation in the IL10−/− model of inflammatory bowel disease. The Journal of Nutritional Biochemistry. 24, 2138–2143;
304. Ramon Greenberg, Chester Pearlman, Richard Blacher, Howard Katz, Jerome Sashin, Phillip Gottlieb. (1990). Depression: Variability of Intrapsychic and Sleep Parameters. Journal of the American Academy of Psychoanalysis. 18, 233–246;
305. T. Yoshida, S. Yamagishi, K. Nakamura, T. Matsui, T. Imaizumi et. al. (2006). Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation. Diabetologia. 49, 3094–3099;
306. Рекомендации Европейского общества кардиологов (ЕОК) и Европейского общества атеросклероза (ЕОА) по лечению дислипидемий. (2011). European Heart Journal. 32, 1769–1818;
307. Pascale Rozan, Amine Nejdi, Sophie Hidalgo, Jean-François Bisson, Didier Desor, Michaël Messaoudi. (2008). Effects of lifelong intervention with an oligofructose-enriched inulin in rats on general health and lifespan. BJN. 100, 1192;
308. Lee-Wen Pai, Pi-Ying Chang, Wei Chen, Yueh-Juen Hwu, Chia-Hsiang Lai. (2012). The effectiveness of physical leisure time activities on glycaemic control in adult patients with diabetes type 2: A Systematic Review. JBI Database of Systematic Reviews and Implementation Reports. 10, 1–20;
309. Jaime Uribarri, Sandra Woodruff, Susan Goodman, Weijing Cai, Xue Chen et. al. (2010). Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet. Journal of the American Dietetic Association. 110, 911–916.e12;
310. Christian Lindmeier, Olivia Lawe Davies. (2015). WHO calls on countries to reduce sugars intake among adults and children. WHO;
311. Cristina Angeloni, Marco Malaguti, Benedetta Rizzo, Maria Cristina Barbalace, Daniele Fabbri, Silvana Hrelia. (2015). Neuroprotective Effect of Sulforaphane against Methylglyoxal Cytotoxicity. Chem. Res. Toxicol. 28, 1234–1245;
312. Ki Mo Kim, Young Sook Kim, Dong Ho Jung, Jun Lee, Jin Sook Kim. (2012). Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose. Experimental Cell Research. 318, 152–159;
313. Sayaka Maeda, Takanori Matsui, Ayako Ojima, Masayoshi Takeuchi, Sho-ichi Yamagishi. (2014). Sulforaphane inhibits advanced glycation end product–induced pericyte damage by reducing expression of receptor for advanced glycation end products. Nutrition Research. 34, 807–813;
314. Sho-ichi Yamagishi, Seiji Ueda, Takanori Matsui, Kazuo Nakamura, Seiya Okuda. (2008). Role of Advanced Glycation End Products (AGEs) and Oxidative Stress in Diabetic Retinopathy. CPD. 14, 962–968;
315. Kazuo Nakamura, Sho-ichi Yamagishi, Yayoi Nakamura, Katsuhiko Takenaka, Takanori Matsui et. al. (2005). Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension. Microvascular. Research. 70, 137–141;
316. Saheem Ahmad, Uzma Shahab, Mohd. Hassan Baig, Mohd. Sajid Khan, M. Salman Khan et. al. (2013). Inhibitory Effect of Metformin and Pyridoxamine in the Formation of Early, Intermediate and Advanced Glycation End-Products. PLoS ONE. 8, e72128;
317. Sonia Del Barco, Alejandro Vazquez-Martin, Sílvia Cufí, Cristina Oliveras-Ferraros, Joaquim Bosch-Barrera et. al. (2011). Metformin: Multi-faceted protection against cancer. Oncotarget. 2;
318. Zhendong Liu, Yingxin Zhao, Fang Wei, Lin Ye, Fanghong Lu et. al. (2014). Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis. Atherosclerosis. 233, 291–299.
319. Freitas A.A., de Magalhães JP. A review and appraisal of the DNA damage theory of ageing. Mutat Res. 2011 Jul-Oct;728(1-2):12-22.
320. Vilenchik M.M., Knudson A.G. Jr. Inverse radiation dose-rate effects on somatic and germ-line mutations and DNA damage rates. Proc Natl Acad Sci U S A. 2000 May 9;97(10):5381-6.
321. Grube K., Bürkle A. Poly(ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span. Proc Natl Acad Sci USA. 1992 Dec 15;89(24):11759-63.
322. Muiras M.L., Müller M., Schächter F., Bürkle A. Increased poly(ADP-ribose) polymerase activity in lymphoblastoid cell lines from centenarians. J Mol Med (Berl). 1998 Apr;76(5):346-54.
323. Chevanne M., Calia C., Zampieri M. et al. Oxidative DNA damage repair and parp 1 and parp 2 expression in Epstein-Barr virus-immortalized B lymphocyte cells from young subjects, old subjects, and centenarians. Rejuvenation Res. 2007 Jun;10(2):191-204.
324. Matsumura H., Mohri Y., Binh N.T. et al. Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis. Science. 2016 Feb 5;351(6273):aad4395.
325. De Luca G., Ventura I., Sanghez V. Prolonged lifespan with enhanced exploratory behavior in mice overexpressing the oxidized nucleoside triphosphatase hMTH1. Aging Cell. 2013 Aug;12(4):695-705.
326. Vermeij W.P., Dollé M.E., Reiling E. et al. Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice. Nature. 2016 Sep 15;537(7620):427-431.
327. Li H., Vogel H., Holcomb V.B. et al. Deletion of Ku70, Ku80, or Both Causes Early Aging without Substantially Increased Cancer. Mol Cell Biol. 2007 Dec; 27(23): 8205–8214.
328. Nie B., Gan W., Shi F. et al. Age-Dependent Accumulation of 8-Oxoguanine in the DNA and RNA in Various Rat Tissues. Oxid Med Cell Longev. 2013; 2013: 303181.
329. Gan W., Liu X.L., Yu T. et al. Urinary 8-oxo-7,8-dihydroguanosine as a Potential Biomarker of Aging. Front Aging Neurosci. 2018 Feb 27;10:34.
330. Zhang Y., Hodgson N.W., Trivedi M.S. et al. Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia. PLoS One. 2016; 11(1): e0146797.
331. Pascale C.L., Miller M.C., Chiu C. et al. Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent. Fluids Barriers CNS. 2011 Jul 8;8:21.
332. Uray I.P., Brown P.H. Chemoprevention of Hormone Receptor-Negative Breast Cancer: New Approaches Needed. Recent Results Cancer Res. 2011; 188: 147–162.
333. Ferrari E., Cravello L., Falvo F. et al. Neuroendocrine features in extreme longevity. Exp Gerontol. 2008 Feb;43(2):88-94.
334. Genazzani A.R., Pluchino N. DHEA replacement for postmenopausal women: have we been looking in the right direction? Climacteric. 2015 Oct;18(5):669-71.
335. Eden J.A. DHEA replacement for postmenopausal women: placebo or panacea? Climacteric. 2015;18(4):439-40.
336. Moore M.A., Weber E., Thornton M., Bannasch P. Sex-dependent, tissue-specific opposing effects of dehydroepiandrosterone on initiation and modulation stages of liver and lung carcinogenesis induced by dihydroxy-di-n-propylnitrosamine in F344 rats. Carcinogenesis. 1988 Aug;9(8):1507-9.
337. Rao M.S., Kashireddy P. Effect of castration on dehydroepiandrosterone-induced hepatocarcinogenesis in male rats. Anticancer Res. 2002 May-Jun;22(3):1409-11.
338. Rao M.S., Subbarao V. Sex differences in dehydroepiandrosterone-induced hepatocarcinogenesis in the rat. ancer Lett. 1998 Mar 13;125(1-2):111-6.
339. Shin S., Im H.J. , Kwon Y.J. Human steroid sulfatase induces Wnt/β-catenin signaling and epithelial-mesenchymal transition by upregulating Twist1 and HIF-1α in human prostate and cervical cancer cells. Oncotarget. 2017 Sep 5; 8(37): 61604–61617.
340. Drori D., Folman Y. Environmental effects on longevity in the male rat: exercise, mating, castration and restricted feeding. Exp Gerontol. 1976;11(1-2):25-32.
341. http://vitals.nbcnews.com/_news/2012/09/24/ 14070451-upside-to-castration-eunuchs-lived-longer-study-finds.
342. Min K.J., Lee C.K., Park H.N. The lifespan of Korean eunuchs. Curr Biol. 2012 Sep 25;22(18):R792-3.
343. Hamilton J.B. , Mestler G.E. Mortality and Survival: Comparison of Eunuchs with Intact Men and Women in a Mentally Retarded Population. J of Gerontol, Vol 24, Issue 4, 1 October 1969, P. 395–411.
344. www.scientificamerican.com/article/why-women-live-longer.
345. www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm436280.htm
346. Nguyen S.M., Ko Ko N., Sattar A.S. et al. Pulmonary Embolism Secondary to Testosterone-Enhancing Herbal Supplement Use. Cureus. 2017 Aug 6;9(8):e1545.
347. Finkle W.D., Greenland S., Ridgeway G.K. et al. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One. 2014 Jan 29;9(1):e85805.
348. Vigen R., O'Donnell C.I., Barón A.E. et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013 Nov 6;310(17):1829-36.
349. Martinez C., Suissa S., Rietbrock S. et al. Testosterone treatment and risk of venous thromboembolism: population based case-control study. BMJ. 2016 Nov 30;355:i5968.
350. Hallengren E., Almgren P., Engström G. et al. Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality: the Malmö Diet and Cancer study. J Am Coll Cardiol. 2014 Oct 7;64(14):1452-60.
351. Metcalf P.A., Kyle C., Kenealy T. et al. HbA1c in relation to incident diabetes and diabetes-related complications in non-diabetic adults at baseline. J Diabetes Complications. 2017 May;31(5):814-823.
352. Kim K.S., Lee Y.M., Lee I.K. Paradoxical associations of insulin resistance with total and cardiovascular mortality in humans. J Gerontol. 2015; 70 (7, 1): 847–853. doi.org/10.1093/gerona/glu194